Cesare has more than 20 years of experience in the drug development field, in both scientific and commercial roles. He is co-founder and Chief Operating Officer of Oncoheroes Biosciences Inc., a Boston-based biotech company exclusively focused on paediatric oncology drug development. Prior to that he held senior positions at AMRI, Aptuit Laurus, ThalesNano and Auxiliis BV. Cesare started his career as research scientist in a pharmaceutical company (Eisai, London) and in academia (Institute of Enzymology, Budapest).
Following the death of his first daughter Laura to cancer, Cesare set up aPODD Foundation, a London-based charity focused on accelerating paediatric oncology drug development. As aPODD’s chairman and trustee he is actively involved on a pro-bono basis in drug repurposing projects, advocacy efforts and research collaborations with other childhood cancer charities.
Cesare holds an MSc in Applied Molecular Biology and a PhD in Neurosciences from UCL, University of London, as well as an MBA from the Central European University, Budapest.
Associate Professor at the Institute of Pharmacy, University of Copenhagen, and at Bioneer, a non-for-profit organization,servicing the Biotech and Pharmaceutical industries. He is a pharmacist and a biologist. He has owned and managed acompounding pharmacy where he gained insight into the problemsof compliance and acceptance of formulations by the patients. StartedEgalet, a drug-delivery company where he worked for more than 20 years. The technologies being Egalet, (erosioncontrolled release dosage forms) and Parvulet (a pediatric formulation). He consults the pharmaceutical, medical-device and cosmetic industries, many of his inventions have matured into marketed products. He is involved in initiatives to improve the medication of pediatric and geriatric therapies and formulations. His “leitmotif” is patient-centric products. He is the inventor of numerous patents, authored papers, reviews, book chapters and assiduously presents his – often unconventional – views in meetings, symposia and interest groups.Heis the co-editor of the AAPS/Springer book “Pediatric Formulations: A roadmap” (2014). Recently, two more companies were founded based on his inventions: Medilet, to market “Dualet”, a dual-chamber syringe for the pre-filled delivery of injectable but labile compounds and Tenacious, owned together with the other four co-inventors for the development of novel buccal carriers of drugs. Apart from teaching pharmaceutical technology, he lectures on intellectual property to pharmacy and business-school students from the inventor’s perspective. He has been involved with the Controlled Release Society, CRS and the American Association of Pharmaceutical Scientists, AAPS as member, invited speaker, presenter, moderator, workshop organizer, as Chairman of the Board of Scientific Advisors for the CRSand more.
Dr. Noreddin received his Ph.D. in Pharmaceutical Sciences from the University of the Pacific, California and received research training as a visiting scholar at the Department of Medicine, Stanford University. He had postdoctoral fellowship (Pharmacokinetics and Pharmacodynamics of Antimicrobials), Department of Medical Microbiology, University of Manitoba followed by an American College of Clinical Pharmacy postdoctoral fellowship (Infectious Diseases). Dr. Noreddin’s research interest includes Pharmacoklinetic/Pharmacodynamic modeling of anti-infective and anti-cancer therapy, clinical simulation and Monte Carlo analysis and bacterial resistance in biofilm studies. Dr. Noreddin has outstanding records of scientific and academic accomplishments with multiple research funding, numerous publications in highly prestigious journals and various presentations in both national and international conferences. He served as a scientific reviewer for the NIH as well as other national and international research institutions.
Claudio J. Salomon, Ph.D., is an Full Professor of Pharmaceutical Technology and is the Head of the Pharmacy Department at the Faculty of Biochemical and Pharmaceutical, National University of Rosario, Rosario, Argentina. He received his B.S. in pharmacy from National University of Rosario (1986). He received his Doctoral Degree in Chemistry at National University of Rosario (1993) and was a postdoctoral fellow at the Hebrew University of Jerusalem (Israel) from 1993 to 1997.
He belongs to the Argentinean National Council Research (CONICET) since 1999. His teaching responsibilities are in undergraduate and PhD programmes, as well as in Latin America-European Union exchange activities. His research interests are in the areas of Pharmaceutical Technology, Drug Delivery, and Biopharmacy including the design of novel drug delivery systems for oral, injectable, buccal and topical administration, as well as the development of novel particle engineering technologies. In recent years, his research activities have focused on the development of novel drug delivery systems for the treatment of several neglected tropical diseases, including Chagas´disease.
He is a recipient of The Mercosur Award in Science and Technology 2012. He has published more than 70 research papers in leading international pharmaceutical and chemical journals. He is an Editor of the AAPS PharmSciTEch journal. He serves on the editorial advisory boards of Pharmaceutical Development and Technology, Molecules and Scientia Pharmaceutica. He is the cofounder of the International Meetings on Pharmaceutical Sciences (RICIFA)
Dr. Ally Dering-Anderson is a Clinical Associate Professor in the Department of Pharmacy Practice & Science at the University of Nebraska College of Pharmacy. A pharmacist immunization advocate, Ally has given more than 40,000 immunizations during her career. Ally was the 2015 Teacher of the Year for the College of Pharmacy and was named a Fellow in APhA in 2017. She also served as the president of the Nebraska Pharmacists Association in 2019. She has been a licensed and practicing pharmacist in Nebraska and Iowa for over 30 years, with experience in community pharmacy, pharmacy associations, and nursing home pharmacy
© 2019 The Talks Media Limited.
© 2019 The Pharma Talks.